SCHEMBL29567154

SCHEMBL29567154

COCc1ccccc1-c1cc(Oc2ccccc2)nc(NS(=O)(=O)c2cccc([N+](=O)[O-])c2)n1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 1/20 0.52
▸ AR P10275 1/20 0.46
▸ LMNA P02545 1/20 0.44
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ DDX3X O00571 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ NFKBIA P25963 1/20 0.41
▸ RELA Q04206 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ F2 P00734 1/20 0.40
▸ PRSS1 P07477 1/20 0.40
▸ PRSS2 P07478 1/20 0.40
▸ PRSS3 P35030 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309297 1.00 PGR (0.52) PGRARLMNAMEN1KMT2A
SCHEMBL29566551 0.89 LMNA (0.44) PGRARLMNAMEN1KMT2A
SCHEMBL24310352 0.89 LMNA (0.44) PGRARLMNAMEN1KMT2A
SCHEMBL26810769 0.88 TSHR (0.50) PGRLMNAMEN1KMT2AALDH1A1
SCHEMBL29568117 0.87 PGR (0.56) PGRARLMNAMEN1KMT2A
SCHEMBL24309602 0.87 PGR (0.56) PGRARLMNAMEN1KMT2A
SCHEMBL24309706 0.86 LMNA (0.42) PGRARLMNAMEN1KMT2A
SCHEMBL29566684 0.85 POLB (0.42) PGRMAPTF2PRSS1PRSS2
SCHEMBL24309644 0.85 POLB (0.42) PGRMAPTF2PRSS1PRSS2
SCHEMBL26812645 0.84 PGR (0.61) PGRARLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback